期刊文献+

分布在不同治疗单元的住院老年2型糖尿病人的降糖方案分析 被引量:4

Analysis of Hypoglycemic Regimen in Elderly Patients with Type 2 Diabetes Mellitus Distributed in Different Treatment Units
原文传递
导出
摘要 目的分析分布在不同治疗单元的老年2型糖尿病人的降糖治疗方案。方法收集368位住院的老年2型糖尿病人资料,分为心血管疾病组、脑血管疾病组、老年病组、内分泌组,评价降糖方案的合理性。结果二甲双胍、阿卡波糖的使用均存在禁忌证(P>0.05),非内分泌专业组使用二甲双胍的不合理现象较多。共有59.2%的病人使用2种以上的降糖药物,出现了降糖药物相互间的作用以及降糖药物与烟酒、降糖药物与其他口服药物的相互作用。结论老年2型糖尿病人的降糖治疗方案需要综合考虑年龄、肝肾功能、胰岛功能、合并疾病、药物相互作用等因素。建议制订住院糖尿病人的管理计划,指定专人负责管理和协调有关住院糖尿病人管理的治疗系统。 OBJECTIVE To analysis of hypoglycemic treatment in elderly type 2 diabetic patients with different treatment units.METHODS Collect 368 data of hospitalized elderly type 2 diabetes patients, Divided into cardiovascular disease group,cerebrovascular disease group,senile disease group,endocrine group. We evaluation of rationality of Sugar reduction Program.RESULTS The use of metformin and acarbose had contraindications( P > 0. 05). There were more unreasonable use of metformin in non-endocrine specialty grup. More than half of the patients use more than 2 hypoglycemic drugs. There were interactions between hypoglycemic drugs,hypoglycemic drugs and tobacco and alcohol,hypoglycemic drugs and other oral drugs. CONCLUSION Age,liver and kidney function,islet function,complicated disease and drug interaction should be taken into account in the treatment of type2 diabetes mellitus. It is recommended that a management plan for hospitalized diabetic patients be drawn up. A designated person is responsible for the management and coordination of the treatment system for hospitalized diabetics.
作者 高玉霞 肖卫东 GAO Yuxia;XIAO Weidong(Department of Pharmacy,Dongying Shengli Hospital,Dongying,Shandong 257055,China)
出处 《今日药学》 CAS 2019年第1期842-845,共4页 Pharmacy Today
关键词 不同治疗单元 住院老年2型糖尿病人 降糖方案分析 different teatment units Hospitalized elderly patients with type 2 diabetes Analysis of hypoglycemic scheme
  • 相关文献

参考文献6

二级参考文献57

  • 1杨文英.磺脲类药物应用专家共识[J].国外医学(内分泌学分册),2004,24(4):255-259. 被引量:75
  • 2李立明,饶克勤,孔灵芝,姚崇华,向红丁,翟凤英,马冠生,杨晓光,中国居民营养与健康状况调查技术执行组.中国居民2002年营养与健康状况调查[J].中华流行病学杂志,2005,26(7):478-484. 被引量:1783
  • 3杨毅,李蓬秋.糖尿病治疗达标的主要障碍——低血糖[J].实用医院临床杂志,2010,7(4):8-11. 被引量:8
  • 4Norberto C Chavez-Tapia,Tonatiuh Barrientos-Gutierrez,Felix I Tellez-ávila,Francisco Sánchez-ávila,Maria Antonieta Montao-Reyes,Misael Uribe.Insulin sensitizers in treatment of nonalcoholic fatty liver disease:Systematic review[J].World Journal of Gastroenterology,2006,12(48):7826-7831. 被引量:11
  • 5贾伟平,陆俊茜,高鑫,邢惠莉,刘伟,刘志民,盛正妍,胡仁明,宁光,邹大进,冯波,项坤三.新诊断2型糖尿病患者一相胰岛素分泌和胰岛素敏感性评估[J].中华内分泌代谢杂志,2007,23(2):100-103. 被引量:32
  • 6[1]Porta M,Trento M.Management of hyperglycemia in type 2 diabetes:a consensus algorithm for the initiation and adjustment of therapy:a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes[J].Diabetes Care,2007,30(1):193.
  • 7[2]Diabetes Prevention Program Research Group.Effects of withdrawal from metformin on the development of diabetes in the diabetes prevention program[J].Diabetes Care,2003,26:977.
  • 8[3]Zhou G,Myers R,Li Y,et al.Role of AMP-activated protein kinase in mechanism of metformin action[J].J Clin Invest,2001.108:1167.
  • 9[4]UK Prospective Diabetes Study(UKPDS)Group.Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes(UKPDS 34)[J].Lancet,1998,352:854.
  • 10[6]Salprter S,Greyber E,Pastemak G,et al.Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus[J].Cochrane Database of Systematic Reviews,2006,25(1):CD002967.

共引文献307

同被引文献45

引证文献4

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部